Perspecta, a leading healthcare technology company, has completed its most successful year in its history. Joseph Kennedy joins the Perspecta team as the new Chief Revenue Officer (CRO), to continue to build upon Perspecta’s market leadership position solutions.
Read More: Pepperl+Fuchs Partners With O9 Solutions To Enable Global End-To-End Integrated Business Planning
In 2020, Perspecta successfully navigated the stormy waters of COVID-19. Despite the challenge to meet with customers and prospects, Perspecta was able to achieve double-digit revenue growth in 2020, and sign agreements with 14 new customers, while deepening engagements with 10 existing Perspecta customers for additional projects due to prior successful deployments.
In order to build upon its position as market leader in the Health Care and Workers’ Compensation solutions space, Perspecta invited Joseph Kennedy to join the team as Chief Revenue Officer (CRO). Kennedy has over 15 years of experience as an individual contributor and manager in enterprise health solutions.
Most recently, Kennedy was Chief Commercial Officer at January.ai, a privately held Artificial Intelligence/Machine Learning company focused on providing personalized recommendations to individuals managing diabetes. Previously, he was a Regional Vice President at Vlocity (recently acquired by Salesforce). Kennedy played a key role in driving growth within Vlocity’s Health Insurance vertical. Kennedy’s experience also includes executive positions at Syapse, a precision-medicine cancer research SaaS company, and Remedy Informatics, a health registries company.
Read More: Coralogix Partners With Webinfinity To Build Solid Foundation For Robust Partner Engagement Program
“I am very excited to be a part of the Perspecta leadership team,” said Kennedy. “I look forward to building upon the company’s current successes and focusing on growing revenue rapidly to better enable healthcare, government, and workers’ compensation organizations to gain sustainable competitive advantages.” Kennedy will also manage business development and partnerships.
In 2021, Perspecta will continue to partner with its customers to develop products that meet the needs of the market. Perspecta is partnering with multiple organizations to launch a plug-and-play provider directory API (“Perspecta TransmitAPI”) that exceeds CMS’ interoperability and Patient Access final rule requirements and deadlines. Perspecta’s TransmitAPI will be launched in February of 2021, giving customers ample time to meet the July 1 deadline set by CMS.
